We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HFWA icon
1601
Heritage Financial
HFWA
$1.21B
$8.01M ﹤0.01%
261,534
+125,328
+92% +$3.92M
VVX icon
1602
V2X
VVX
$2.65B
$8.01M ﹤0.01%
194,082
-21,668
-10% -$859K
STNG icon
1603
Scorpio Tankers
STNG
$3.81B
$8.01M ﹤0.01%
148,977
-27,663
-16% -$1.38M
MTG icon
1604
MGIC Investment
MTG
$6.25B
$8.01M ﹤0.01%
616,013
-139,377
-18% -$1.83M
OXM icon
1605
Oxford Industries
OXM
$552M
$8.01M ﹤0.01%
85,907
+23,121
+37% +$2.31M
CNI icon
1606
Canadian National Railway
CNI
$76.6B
$8M ﹤0.01%
67,284
-9,920
-13% -$1.19M
TXG icon
1607
10x Genomics
TXG
$6.61B
$7.99M ﹤0.01%
219,338
-5,533
-2% -$181K
ACAD icon
1608
Acadia Pharmaceuticals
ACAD
$5.03B
$7.96M ﹤0.01%
500,077
-428,896
-46% -$6.7M
MCHB
1609
Mechanics Bancorp
MCHB
$3.68B
$7.95M ﹤0.01%
288,326
-194,365
-40% -$5.32M
KMT icon
1610
Kennametal
KMT
$2.52B
$7.95M ﹤0.01%
330,477
-118,243
-26% -$2.93M
EHAB
1611
DELISTED
Enhabit
EHAB
$7.92M ﹤0.01%
602,008
+232,494
+63% +$3.1M
PAYO icon
1612
Payoneer
PAYO
$2.41B
$7.92M ﹤0.01%
1,448,155
-285,534
-16% -$1.79M
BZ icon
1613
Kanzhun
BZ
$7.36B
$7.9M ﹤0.01%
387,800
-63,525
-14% -$1.04M
CTRE icon
1614
CareTrust REIT
CTRE
$9.74B
$7.9M ﹤0.01%
425,202
-160,215
-27% -$2.99M
THRM icon
1615
Gentherm
THRM
$1.27B
$7.88M ﹤0.01%
120,761
-14,343
-11% -$927K
WLY icon
1616
John Wiley & Sons Class A
WLY
$2.66B
$7.87M ﹤0.01%
196,377
-5,955
-3% -$249K
CFLT
1617
DELISTED
Confluent
CFLT
$7.85M ﹤0.01%
353,059
+11,156
+3% +$258K
CTIC
1618
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$7.83M ﹤0.01%
1,303,552
-49,957
-4% -$273K
ABR icon
1619
Arbor Realty Trust
ABR
$998M
$7.83M ﹤0.01%
593,286
+36,170
+6% +$491K
SFNC icon
1620
Simmons First National
SFNC
$3.39B
$7.83M ﹤0.01%
362,614
-64,153
-15% -$1.46M
BFH icon
1621
Bread Financial
BFH
$4.38B
$7.81M ﹤0.01%
207,408
-22,419
-10% -$809K
BANF icon
1622
BancFirst
BANF
$3.8B
$7.79M ﹤0.01%
88,324
+17,352
+24% +$1.64M
UNIT
1623
Uniti Group
UNIT
$2.32B
$7.78M ﹤0.01%
1,407,357
+319,185
+29% +$2.19M
WERN icon
1624
Werner Enterprises
WERN
$2.25B
$7.77M ﹤0.01%
193,041
-30,643
-14% -$1.25M
CARS icon
1625
Cars.com
CARS
$660M
$7.77M ﹤0.01%
564,226
+50,937
+10% +$690K

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.